Pharmacology and Toxicology - Faculty
Jonathan Hommel, Ph.D.
Phone: (409) 747-7057
Research Information Page
08/01 – 06/05 Ph.D., Integrative Biology (primary focus in neuroscience)
University of Texas Southwestern Medical Center, Dallas, TX
01/98 – 12/00 B.S., Genetics, cum laude
Texas A&M University, College Station, TX
08/96 – 12/97 Chemical Engineering
McNeese State University,
Lake Charles, LA
My research career began at Texas A&M University where I studied plant genomics and crop biotechnology as an undergraduate research fellow. Then, I became a molecular neuroscientist during my predoctoral fellowship with Dr. Ralph DiLeone at the University of Texas Southwestern Medical Center and a postdoctoral fellow at Duke University, establishing numerous innovative techniques including viral RNAi knockdown. I then transitioned to an Investigator with the pharmaceutical company GlaxoSmithKline (GSK), where I expanded my expertise to include in vivo behavioral assays. I established a variety of assays to evaluate different components of feeding behavior, including operant responding for food, sucrose preference, fat preference, and binge eating. Furthermore, my time at GSK afforded me the experience of building and maintaining a research program as well as procuring funding/resources for our department. My research at GSK is highlighted by the progression of two compounds to first time clinical research in humans for the treatment of obesity and potentially eating disorders. Now, as an assistant professor in the department of Pharmacology & Toxicology within the Center for Addiction Research, my research focuses on the molecular mechanisms and neural pathways underlying motivated behavior and food reward.